{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:52:41Z","timestamp":1789707161546,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T00:00:00Z","timestamp":1410220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00213-014-3721-0","type":"journal-article","created":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T00:31:50Z","timestamp":1410136310000},"page":"871-883","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Inhaled vs. oral alprazolam: subjective, behavioral and cognitive effects, and modestly increased abuse potential"],"prefix":"10.1007","volume":"232","author":[{"given":"Chad J.","family":"Reissig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence P.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland R.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,9]]},"reference":[{"key":"3721_CR1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s002130000624","volume":"154","author":"ME Abreu","year":"2001","unstructured":"Abreu ME, Bigelow GE, Fleisher L, Walsh SL (2001) Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. Psychopharmacol (Berl) 154:76\u201384","journal-title":"Psychopharmacol (Berl)"},{"key":"3721_CR2","unstructured":"Alexza Pharmaceuticals (2014a) Investigator\u2019s brochure for study AZ-002"},{"key":"3721_CR3","unstructured":"Alexza Pharmaceuticals (2014b) Product Website frequently asked questions (FAQ). Available online at: http:\/\/www.alexza.com\/products\/faq . Accessed 30 May 2014"},{"key":"3721_CR4","unstructured":"Alexza Pharmaceuticals (2014c) Product Website frequently asked questions (FAQ). Available online at: http:\/\/www.alexza.com\/products\/faq . Accessed on June 26, 2014"},{"key":"3721_CR5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/dmd.106.010652","volume":"35","author":"MJ Avram","year":"2007","unstructured":"Avram MJ, Henthorn TK, Spyker DA, Krejcie TC, Lloyd PM, Cassella JV, Rabinowitz JD (2007) Recirculatory pharmacokinetic model of the uptake, distribution, and bioavailability of prochlorperazine administered as a thermally generated aerosol in a single breath to dogs. Drug Metab Dispos 35:262\u2013267","journal-title":"Drug Metab Dispos"},{"key":"3721_CR6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/clpt.2008.184","volume":"85","author":"MJ Avram","year":"2009","unstructured":"Avram MJ, Spyker DA, Henthorn TK, Cassella JV (2009) The pharmacokinetics and bioavailability of prochlorperazine delivered as a thermally generated aerosol in a single breath to volunteers. Clin Pharmacol Ther 85:71\u201377","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"3721_CR7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0091270012436886","volume":"53","author":"MJ Avram","year":"2013","unstructured":"Avram MJ, Spyker DA, Kehne JH, Cassella JV (2013) The pharmacokinetics and pharmacodynamics of zaleplon delivered as a thermally generated aerosol in a single breath to volunteers. J Clin Pharmacol 53(2):140\u2013150","journal-title":"J Clin Pharmacol"},{"key":"3721_CR8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1901\/jeab.1973.20-119","volume":"20","author":"RL Balster","year":"1973","unstructured":"Balster RL, Schuster CR (1973) Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J Exp Anal Behav 20:119\u2013129","journal-title":"J Exp Anal Behav"},{"key":"3721_CR9","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.npp.1301146","volume":"31","author":"LP Carter","year":"2006","unstructured":"Carter LP, Richards BD, Mintzer MZ, Griffiths RR (2006) Relative abuse liability of GHB in humans: a comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. Neuropsychopharmacology 31:2537\u20132551","journal-title":"Neuropsychopharmacology"},{"key":"3721_CR10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-009-1589-1","volume":"206","author":"LP Carter","year":"2009","unstructured":"Carter LP, Griffiths RR, Mintzer MZ (2009) Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers. Psychopharmacol (Berl) 206:141\u2013154","journal-title":"Psychopharmacol (Berl)"},{"key":"3721_CR11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/BF02245161","volume":"107","author":"H Wit de","year":"1992","unstructured":"de Wit H, Bodker B, Ambre J (1992) Rate of increase of plasma drug level influences subjective response in humans. Psychopharmacol (Berl) 107:352\u2013358","journal-title":"Psychopharmacol (Berl)"},{"key":"3721_CR12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/BF02244928","volume":"112","author":"H Wit de","year":"1993","unstructured":"de Wit H, Dudish S, Ambre J (1993) Subjective and behavioral effects of diazepam depend on its rate of onset. Psychopharmacol (Berl) 112:324\u2013330","journal-title":"Psychopharmacol (Berl)"},{"key":"3721_CR13","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0022-3565(25)23193-7","volume":"255","author":"SM Evans","year":"1990","unstructured":"Evans SM, Funderburk FR, Griffiths RR (1990) Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 255:1246\u20131255","journal-title":"J Pharmacol Exp Ther"},{"key":"3721_CR14","first-page":"570","volume":"43","author":"MW Fischman","year":"1984","unstructured":"Fischman MW, Schuster CR (1984) Injection duration of cocaine in humans. Fed Poc 43:570","journal-title":"Fed Poc"},{"key":"3721_CR15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1054-3589(08)60914-X","volume":"42","author":"DA Gorelick","year":"1998","unstructured":"Gorelick DA (1998) The rate hypothesis and agonist substitution approaches to cocaine abuse treatment. Adv Pharmacol 42:995\u2013997","journal-title":"Adv Pharmacol"},{"key":"3721_CR16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00003088-199324060-00003","volume":"24","author":"DJ Greenblatt","year":"1993","unstructured":"Greenblatt DJ, Wright CE (1993) Clinical pharmacokinetics of alprazolam. Therapeutic implications. Clin Pharmacokinet 24:453\u2013471","journal-title":"Clin Pharmacokinet"},{"key":"3721_CR17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00427437","volume":"84","author":"RR Griffiths","year":"1984","unstructured":"Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD (1984) Relative abuse liability of diazepam and oxazepam: behavioral and subjective dose effects. Psychopharmacol (Berl) 84:147\u2013154","journal-title":"Psychopharmacol (Berl)"},{"key":"3721_CR18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0149-7634(85)90039-9","volume":"9","author":"RR Griffiths","year":"1985","unstructured":"Griffiths RR, Lamb RJ, Ator NA, Roache JD, Brady JV (1985) Relative abuse liability of triazolam: experimental assessment in animals and humans. Neurosci Biobehav Rev 9:133\u2013151","journal-title":"Neurosci Biobehav Rev"},{"key":"3721_CR19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0091-3057(87)90462-X","volume":"28","author":"S Kato","year":"1987","unstructured":"Kato S, Wakasa Y, Yanagita T (1987) Relationship between minimum reinforcing doses and injection speed in cocaine and pentobarbital self-administration in crab-eating monkeys. Pharmacol Biochem Behav 28:407\u2013410","journal-title":"Pharmacol Biochem Behav"},{"key":"3721_CR20","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1213\/ANE.0b013e3182691898","volume":"115","author":"DB Macleod","year":"2012","unstructured":"Macleod DB, Habib AS, Ikeda K, Spyker DA, Cassella JV, Ho KY, Gan TJ (2012) Inhaled fentanyl aerosol in healthy volunteers: pharmacokinetics and pharmacodynamics. Anesth Analg 115:1071\u20131077","journal-title":"Anesth Analg"},{"key":"3721_CR21","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0022-3565(24)29229-6","volume":"299","author":"LA Marsch","year":"2001","unstructured":"Marsch LA, Bickel WK, Badger GJ, Rathmell JP, Swedberg MD, Jonzon B, Norsten-Hoog C (2001) Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans. J Pharmacol Exp Ther 299:1056\u20131065","journal-title":"J Pharmacol Exp Ther"},{"key":"3721_CR22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3758\/BF03203313","volume":"14","author":"DR McLeod","year":"1982","unstructured":"McLeod DR, Griffiths RR, Bigelow GE, Yingling J (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Methods & Instrum 14:463\u2013466","journal-title":"Behav Res Methods & Instrum"},{"key":"3721_CR23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0009-9236(95)90162-0","volume":"57","author":"GK Mumford","year":"1995","unstructured":"Mumford GK, Evans SM, Fleishaker JC, Griffiths RR (1995a) Alprazolam absorption kinetics affects abuse liability. Clin Pharmacol Ther 57:356\u2013365","journal-title":"Clin Pharmacol Ther"},{"key":"3721_CR24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-3565(25)24438-X","volume":"272","author":"GK Mumford","year":"1995","unstructured":"Mumford GK, Rush CR, Griffiths RR (1995b) Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects. J Pharmacol Exp Ther 272:570\u2013580","journal-title":"J Pharmacol Exp Ther"},{"key":"3721_CR25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.drugalcdep.2005.08.004","volume":"82","author":"RA Nelson","year":"2006","unstructured":"Nelson RA, Boyd SJ, Ziegelstein RC, Herning R, Cadet JL, Henningfield JE, Schuster CR, Contoreggi C, Gorelick DA (2006) Effect of rate of administration on subjective and physiological effects of intravenous cocaine in humans. Drug Alcohol Depend 82:19\u201324","journal-title":"Drug Alcohol Depend"},{"key":"3721_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/NSS.S6431","volume":"2","author":"DN Neubauer","year":"2010","unstructured":"Neubauer DN (2010) ZolpiMist: a new formulation of zolpidem tartrate for the short-term treatment of insomnia in the US. Nat Sci Sleep 2:79\u201384","journal-title":"Nat Sci Sleep"},{"key":"3721_CR27","first-page":"13","volume":"120","author":"WH Oldendorf","year":"1992","unstructured":"Oldendorf WH (1992) Some relationships between addiction and drug delivery to the brain. NIDA Res Monogr 120:13\u201325","journal-title":"NIDA Res Monogr"},{"key":"3721_CR28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1124\/jpet.103.062893","volume":"309","author":"JD Rabinowitz","year":"2004","unstructured":"Rabinowitz JD, Wensley M, Lloyd P, Myers D, Shen W, Lu A, Hodges C, Hale R, Mufson D, Zaffaroni A (2004) Fast onset medications through thermally generated aerosols. J Pharmacol Exp Ther 309:769\u2013775","journal-title":"J Pharmacol Exp Ther"},{"key":"3721_CR29","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/jps.20694","volume":"95","author":"JD Rabinowitz","year":"2006","unstructured":"Rabinowitz JD, Lloyd PM, Munzar P, Myers DJ, Cross S, Damani R, Quintana R, Spyker DA, Soni P, Cassella JV (2006) Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation. J Pharm Sci 95:2438\u20132451","journal-title":"J Pharm Sci"},{"key":"3721_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-012-2680-6","volume":"223","author":"CJ Reissig","year":"2012","unstructured":"Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR (2012) High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacol (Berl) 223:1\u201315","journal-title":"Psychopharmacol (Berl)"},{"key":"3721_CR31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0376-8716(01)00127-2","volume":"64","author":"PN Roset","year":"2001","unstructured":"Roset PN, Farre M, de la Torre R, Mas M, Menoyo E, Hernandez C, Cami J (2001) Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males. Drug Alcohol Depend 64:285\u2013298","journal-title":"Drug Alcohol Depend"},{"key":"3721_CR32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s002130051030","volume":"145","author":"CR Rush","year":"1999","unstructured":"Rush CR, Frey JM, Griffiths RR (1999) Zaleplon and triazolam in humans: acute behavioral effects and abuse potential. Psychopharmacol (Berl) 145:39\u201351","journal-title":"Psychopharmacol (Berl)"},{"key":"3721_CR33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF00431449","volume":"84","author":"RB Smith","year":"1984","unstructured":"Smith RB, Kroboth PD, Vanderlugt JT, Phillips JP, Juhl RP (1984) Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration. Psychopharmacol (Berl) 84:452\u2013456","journal-title":"Psychopharmacol (Berl)"},{"key":"3721_CR34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/0091270009347866","volume":"50","author":"DA Spyker","year":"2010","unstructured":"Spyker DA, Munzar P, Cassella JV (2010) Pharmacokinetics of loxapine following inhalation of a thermally generated aerosol in healthy volunteers. J Clin Pharmacol 50:169\u2013179","journal-title":"J Clin Pharmacol"},{"key":"3721_CR35","first-page":"53","volume":"15","author":"Y Wakasa","year":"1995","unstructured":"Wakasa Y, Takada K, Yanagita T (1995) Reinforcing effect as a function of infusion speed in intravenous self-administration of nicotine in rhesus monkeys. Nihon Shinkei Seishin Yakurigaku Zasshi 15:53\u201359","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"3721_CR36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejphar.2004.01.003","volume":"486","author":"WL Woolverton","year":"2004","unstructured":"Woolverton WL, Wang Z (2004) Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine. Eur J Pharmacol 486:251\u2013257","journal-title":"Eur J Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3721-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-014-3721-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3721-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T10:26:54Z","timestamp":1746354414000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-014-3721-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["3721"],"URL":"https:\/\/doi.org\/10.1007\/s00213-014-3721-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,9]]}}}